Dental News - Henry Schein expands its global dental implant business

Dental Tribune International

Wed. 26. September 2018

save

MELVILLE, N.Y., U.S.: Henry Schein, the world's largest provider of healthcare products and services to office-based dental, animal health, and medical practitioners, has announced three separate investments that will advance the company's dental implant business strategy.

The company’s acquisition of Intra-Lock, a U.S.-based dental implant manufacturing and sales business, is intended to enhance Henry Schein’s position in the premium implant segment. Its expansion into the lower-priced segment of the dental implant market, on the other hand, has been made clear through the planned acquisition of a majority interest in Medentis Medical, a dental implant manufacturer based in Germany. Henry Schein also strengthens its geographic footprint in Europe with the acquisition of a majority interest in Pro-Cam Implants B.V., CAMLOG's exclusive distributor in the Netherlands. Financial terms for these acquisitions were not disclosed.

"As a member of the Henry Schein family, we see tremendous opportunities to continue our legacy of product innovation,” said Dr. Thierry Giorno, CEO and Director of Research and Development at Intra-Lock.

“We look forward to joining forces with the Henry Schein team to accelerate our growth and to develop and identify technologies that can be leveraged to create next-generation products for BioHorizons and CAMLOG product lines,” continued Giorno.

"With this new ownership position by Henry Schein, Medentis will accelerate several important, ongoing strategic initiatives including expanding our position in the fast-growing emerging markets," commented Medentis founder and CEO, Alexander Scholz. "My father ran a dental laboratory and I have spent my entire career in the dental industry, including serving as Practice Manager of an implant center in Cologne. As such, I fully appreciate the importance of quality products, value and excellent customer service. I am delighted to be aligning Medentis with the global dental leader Henry Schein, and look forward to the many opportunities to advance the practice of dentistry."

Stanley M. Bergman, Chairman of the Board and Chief Executive Officer of Henry Schein, added, "The dental implant category has become increasingly important and we are committed to offering customers a wide array of the products and services associated with implant dentistry, thereby providing a complete solution for the benefit of the dental practice.”

Bergman continued, "We believe that with the investments we have made in CAMLOG, BioHorizons and now Intra-Lock, Medentis Medical and Pro-Cam Implants, we are well positioned to compete in the high growth global dental implant market. We welcome our new colleagues to Team Schein and look forward to continued success together."